Axinn partner Chad Landmon served as one of nine associate editors of the American Bar Association publication, "Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio, Second Edition."

ANDA patent litigations and strategies are complex, requiring that the patent professional can explain complex technical and legal issues to lay persons, both within the organization and to judges and juries. Now completely updated, this compendium provides lawyers with authoritative, in-depth information, tactics, and advice so that any pharmaceutical litigant wanting to increase market share, whether as an innovator or a generic, can plan early and be prepared to alter plans as new events occur.

Click here for more information about this publication.